ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,089.48
0.05%
Dow Jones
43,408.47
0.32%
Gold vs US Dollar
2,669.485
0.64%
Brent Oil
73.335
0.68%
Bitcoin
97,589.10
3.42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) News

Gsk (GSK)

Gsk Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GSK
DateTimeSourceHeadlineSymbolCompany
19/11/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
19/11/202409:24Alliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
19/11/202409:24Alliance NewsAlliance NewsGSK hails positive results for linerixibat in treating relentless itchLSE:GSKGsk Plc
19/11/202407:00RNS Regulatory NewsGSK PLC GLISTEN Trial of Linerixibat Meets EndpointLSE:GSKGsk Plc
14/11/202408:54Alliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
14/11/202408:54Alliance NewsAlliance NewsGSK hails survival results in blood cancer patients with BlenrepLSE:GSKGsk Plc
14/11/202407:00RNS Regulatory NewsGSK PLC GSK announces overall survival results for BlenrepLSE:GSKGsk Plc
13/11/202415:00RNS Regulatory NewsGSK PLC Block listing Interim ReviewLSE:GSKGsk Plc
12/11/202415:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
11/11/202415:01RNS Regulatory NewsGSK PLC GSK publishes provisional 2025 dividend datesLSE:GSKGsk Plc
04/11/202416:16Alliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
04/11/202416:16Alliance NewsAlliance NewsDIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sellsLSE:GSKGsk Plc
01/11/202415:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
30/10/202414:29RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
30/10/202409:28Alliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
30/10/202409:28Alliance NewsAlliance NewsTOP NEWS: GSK backs guidance despite third-quarter hit from ZantacLSE:GSKGsk Plc
30/10/202407:00RNS Regulatory NewsGSK PLC 3rd Quarter ResultsLSE:GSKGsk Plc
29/10/202412:48Alliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
29/10/202412:48Alliance NewsAlliance NewsGSK inks deal to buy lupus therapy from Chimagen for USD300 millionLSE:GSKGsk Plc
24/10/202408:22Alliance NewsAlliance NewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSVLSE:GSKGsk Plc
24/10/202408:22Alliance NewsAlliance NewsIN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSVLSE:GSKGsk Plc
24/10/202406:00RNS Regulatory NewsGSK PLC New positive Arexvy data in younger adults at riskLSE:GSKGsk Plc
17/10/202414:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
16/10/202415:09RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
16/10/202407:33Alliance NewsAlliance NewsGSK's application for urinary tract infections drug is acceptedLSE:GSKGsk Plc
16/10/202407:33Alliance NewsAlliance NewsGSK's application for urinary tract infections drug is acceptedLSE:GSKGsk Plc
16/10/202406:00RNS Regulatory NewsGSK PLC FDA accepts new drug application for gepotidacinLSE:GSKGsk Plc
14/10/202414:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
14/10/202407:54Alliance NewsAlliance NewsTOP NEWS: GSK gets positive result from sinus disease treatment trialsLSE:GSKGsk Plc
14/10/202407:54Alliance NewsAlliance NewsTOP NEWS: GSK gets positive result from sinus disease treatment trialsLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Your Recent History

LSE
STX
Shield Therapeutics
LSE
POLX
Polarean Imaging
LSE
POS
Plexus
LSE
LLOY
Lloyds Banking
LSE
LIO
Liontrust Asset Management
LSE
JD.
Jd Sports Fashion
LSE
NESF
Nextenergy Solar
LSE
MIN
Minoan
LSE
VAST
Vast Resources
LSE
AAZ
Anglo Asian Mining
LSE
BARC
Barclays
LSE
SYME
Supply@me Capital
LSE
NEXN
Nexxen
LSE
EME
Empyrean Energy
LSE
NFDS
Northern Foods
LSE
JET2
Jet2
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06